{"questions":[{"id":"open_question-c5fae337-6322-40ce-8f30-84c5a4b44403","artifact_type":"open_question","title":"How does cell-to-cell transmission differ between sporadic and genetic forms of PD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:36.674651+00:00","updated_at":"2026-04-26T03:27:36.674651+00:00"},{"id":"open_question-2b200597-20fa-47d4-bb9a-0832b4162507","artifact_type":"open_question","title":"What is the therapeutic window for [LRRK2](/entities/lrrk2) kinase inhibition in PD patients?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:36.801487+00:00","updated_at":"2026-04-26T03:27:36.801487+00:00"},{"id":"open_question-c472a9ec-c924-4ed6-9d86-e17ee219ee8c","artifact_type":"open_question","title":"What are the optimal timing windows for disease-modifying interventions?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:37.189340+00:00","updated_at":"2026-04-26T03:27:37.189340+00:00"},{"id":"open_question-661a6e00-d2cc-4205-a584-85d5caa59800","artifact_type":"open_question","title":"What is the relationship between sleep disorders and PD pathogenesis?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:37.385902+00:00","updated_at":"2026-04-26T03:27:37.385902+00:00"},{"id":"open_question-fb8cb18c-d027-4ec3-b4da-e070ee7489f6","artifact_type":"open_question","title":"How does intestinal permeability affect alpha-synuclein aggregation?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:37.691165+00:00","updated_at":"2026-04-26T03:27:37.691165+00:00"},{"id":"open_question-a6da4a2c-7419-4579-bfcf-7c69551a5784","artifact_type":"open_question","title":"How can biomarker-defined subtypes guide personalized treatment?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:52.738725+00:00","updated_at":"2026-04-26T03:25:52.738725+00:00"},{"id":"open_question-6989b61e-efe5-4f7f-ab8a-440af0791a22","artifact_type":"open_question","title":"How can biomarker-defined subtypes guide personalized treatment?**: Emerging data suggests different therapeutic responses based on biomarker profiles (e.g., tau burden, APOE status). How should treat","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:53.186667+00:00","updated_at":"2026-04-26T03:25:53.186667+00:00"},{"id":"open_question-1798a058-ba71-4bf2-9a42-e0ec9628c0af","artifact_type":"open_question","title":"What mechanisms drive severe sleep-disordered breathing and stridor progression in high-risk patients?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:02.639096+00:00","updated_at":"2026-04-26T03:29:02.639096+00:00"},{"id":"open_question-00da591c-d299-4e91-8c48-34cdb7da5656","artifact_type":"open_question","title":"How should combination therapies balance anti-aggregation, mitochondrial, and anti-inflammatory targets in MSA?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:02.721116+00:00","updated_at":"2026-04-26T03:29:02.721116+00:00"},{"id":"open_question-d10af2df-2f00-4a90-9bc7-8fa615418b0e","artifact_type":"open_question","title":"What patient-centered endpoints best capture autonomic and quality-of-life benefit beyond motor scales?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:02.797996+00:00","updated_at":"2026-04-26T03:29:02.797996+00:00"},{"id":"open_question-diseases-huntingtons-669ca092","artifact_type":"open_question","title":"Gene silencing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-huntingtons-8f13d270","artifact_type":"open_question","title":"Aggregation inhibitors","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-huntingtons-7943a8b2","artifact_type":"open_question","title":"Neuroprotective","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-post-covid-neurological-syndrome-6ee76384","artifact_type":"open_question","title":"Biomarker-guided therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-psp-non-western-populations-90bd5e9e","artifact_type":"open_question","title":"Clinical phenotype documentation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-psp-non-western-populations-bf1f1258","artifact_type":"open_question","title":"Healthcare access research","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-7b3f31ee-de65-4346-a7e4-e439a3ac1b3f","artifact_type":"open_question","title":"How does progranulin insufficiency alter lysosomal and immune function in vulnerable cortical networks?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:14.496179+00:00","updated_at":"2026-04-26T03:29:14.496179+00:00"},{"id":"open_question-470a6f62-050f-495f-bd5a-88a7256539a9","artifact_type":"open_question","title":"Why oligodendrocytes?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:19.941398+00:00","updated_at":"2026-04-26T03:28:19.941398+00:00"},{"id":"open_question-ea6b51f1-c30e-41e7-a9eb-ed463c444063","artifact_type":"open_question","title":"What is the precise sequence of events in preclinical AD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:51.966299+00:00","updated_at":"2026-04-26T03:25:51.966299+00:00"},{"id":"open_question-9589e4ba-6b69-47aa-85e1-075d4e3369ad","artifact_type":"open_question","title":"What drives the selective vulnerability of specific neuronal populations?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:52.143941+00:00","updated_at":"2026-04-26T03:25:52.143941+00:00"},{"id":"open_question-24f5af72-1a3b-4c8e-8760-a8977d5b2051","artifact_type":"open_question","title":"Can blood biomarkers reliably detect preclinical AD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:52.217071+00:00","updated_at":"2026-04-26T03:25:52.217071+00:00"},{"id":"open_question-9126efda-a03d-4a03-9c20-19c4fb54e06e","artifact_type":"open_question","title":"How can we effectively target tau pathology?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:52.433455+00:00","updated_at":"2026-04-26T03:25:52.433455+00:00"},{"id":"open_question-ef47b99b-4a53-4568-93e0-a7a8c9264a1c","artifact_type":"open_question","title":"Can combination therapy approaches improve outcomes over monotherapy?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:52.674747+00:00","updated_at":"2026-04-26T03:25:52.674747+00:00"},{"id":"open_question-8fe16091-3894-463c-9e52-0db0f2285c66","artifact_type":"open_question","title":"What is the therapeutic potential of TREM2 modulators?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:52.815367+00:00","updated_at":"2026-04-26T03:25:52.815367+00:00"},{"id":"open_question-92a1dc22-50ef-4e7a-85d5-1515c92187df","artifact_type":"open_question","title":"How do we address tau pathology beyond antibody approaches?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:52.899876+00:00","updated_at":"2026-04-26T03:25:52.899876+00:00"},{"id":"open_question-2298648a-baf3-4fed-8fb8-573e8de707cc","artifact_type":"open_question","title":"How should AD risk be communicated and acted upon?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:53.032002+00:00","updated_at":"2026-04-26T03:25:53.032002+00:00"},{"id":"open_question-a4aece28-88e0-4cef-83db-2c5a4a22d6a0","artifact_type":"open_question","title":"Why do Lewy bodies spread in a predictable pattern?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:08.781973+00:00","updated_at":"2026-04-26T03:27:08.781973+00:00"},{"id":"open_question-494c77d4-2a43-42c6-9c71-53010f10f22d","artifact_type":"open_question","title":"What determines whether C9orf72 carriers develop FTLD, ALS, or both phenotypes?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:27.726618+00:00","updated_at":"2026-04-26T03:26:27.726618+00:00"},{"id":"open_question-1b0a5ad4-fdb5-4e81-bd77-f6c16fb2a0d8","artifact_type":"open_question","title":"Are there shared therapeutic targets between FTLD and ALS that could benefit both patient populations?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:27.785501+00:00","updated_at":"2026-04-26T03:26:27.785501+00:00"},{"id":"open_question-diseases-advanced-rehabilitation-technologies-cortico-basal-syndrome-56afa528","artifact_type":"open_question","title":"Wearable sensors","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-advanced-rehabilitation-technologies-cortico-basal-syndrome-35ceef95","artifact_type":"open_question","title":"Artificial intelligence","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-advanced-rehabilitation-technologies-cortico-basal-syndrome-07929a1b","artifact_type":"open_question","title":"Telerehabilitation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-advanced-rehabilitation-technologies-cortico-basal-syndrome-9f9b93d5","artifact_type":"open_question","title":"Brain stimulation integration","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-advanced-rehabilitation-technologies-cortico-basal-syndrome-06730ce9","artifact_type":"open_question","title":"Personalized neurofeedback","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-d4c951e8","artifact_type":"open_question","title":"Mutation-specific therapies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-6737ef5a","artifact_type":"open_question","title":"Personalized medicine","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-9b6ce13d","artifact_type":"open_question","title":"Pharmacogenomics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-9cf0fbb3","artifact_type":"open_question","title":"Gene therapy plus metabolic supplementation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-4d955429","artifact_type":"open_question","title":"Cell therapy plus pharmacological agents","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-8b45d8f5","artifact_type":"open_question","title":"Dietary modification plus pharmacological support","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-ccfea96f","artifact_type":"open_question","title":"Carrier screening","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-ff2eaa0c","artifact_type":"open_question","title":"Prenatal diagnosis","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-d65dcd1a","artifact_type":"open_question","title":"Preimplantation genetic diagnosis","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-zellweger-syndrome-23ac8939","artifact_type":"open_question","title":"Newborn screening","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-epidemiology-neurodegenerative-diseases-e831cf38","artifact_type":"open_question","title":"Harmonized diagnostic criteria","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-epidemiology-neurodegenerative-diseases-e23403ad","artifact_type":"open_question","title":"Biomarker-based studies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-epidemiology-neurodegenerative-diseases-a7220870","artifact_type":"open_question","title":"Large-scale genomic studies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-epidemiology-neurodegenerative-diseases-3113f19a","artifact_type":"open_question","title":"Population-based cohort studies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-post-covid-neurological-syndrome-4a8fb770","artifact_type":"open_question","title":"Genetic profiling","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-post-covid-neurological-syndrome-3ebd470f","artifact_type":"open_question","title":"Precision rehabilitation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-post-covid-neurological-syndrome-c449e07b","artifact_type":"open_question","title":"Vaccination impact","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-post-covid-neurological-syndrome-4892d91a","artifact_type":"open_question","title":"Early intervention","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-post-covid-neurological-syndrome-0bab6963","artifact_type":"open_question","title":"Risk factor modification","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-psp-non-western-populations-5b041ce6","artifact_type":"open_question","title":"Epidemiological studies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-psp-non-western-populations-13e3b151","artifact_type":"open_question","title":"Genetic characterization","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-msa-genetic-variants-43057e7f","artifact_type":"open_question","title":"Diverse population studies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-msa-genetic-variants-58ec6e0e","artifact_type":"open_question","title":"Functional validation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-msa-genetic-variants-eb3a188e","artifact_type":"open_question","title":"Gene-environment interactions","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-msa-genetic-variants-c5dcf2c4","artifact_type":"open_question","title":"Therapeutic targeting","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-6cd60ea2","artifact_type":"open_question","title":"Blood-based biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-8ebc8163","artifact_type":"open_question","title":"Imaging biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-f7745275","artifact_type":"open_question","title":"CSF biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-e1b2ecbd","artifact_type":"open_question","title":"Combined biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-8046087e","artifact_type":"open_question","title":"Astrocyte-targeting therapies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-49476917","artifact_type":"open_question","title":"Anti-propagation strategies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-fafca908","artifact_type":"open_question","title":"Tau aggregation inhibitors","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-aa632b95","artifact_type":"open_question","title":"Anti-inflammatory agents","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-2d35c7df","artifact_type":"open_question","title":"Longitudinal cohorts","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-c2502164","artifact_type":"open_question","title":"Standardization","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-aging-related-tau-astrogliopathy-8cf21276","artifact_type":"open_question","title":"Multi-center collaboration","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-frontotemporal-dementia-fe3925da","artifact_type":"open_question","title":"TDP-43 Pathology","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-frontotemporal-dementia-58e137aa","artifact_type":"open_question","title":"Genetic Architecture","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-frontotemporal-dementia-882f8d1c","artifact_type":"open_question","title":"Clinical Heterogeneity","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-frontotemporal-dementia-99516549","artifact_type":"open_question","title":"Therapeutic Targets","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-frontotemporal-dementia-882ec736","artifact_type":"open_question","title":"ALS Overlap","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-4d5788cc","artifact_type":"open_question","title":"Blood-based tests","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-8ebc8163","artifact_type":"open_question","title":"Imaging biomarkers","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-811c2921","artifact_type":"open_question","title":"Genetic testing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-28be74de","artifact_type":"open_question","title":"Disease-modifying trials","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-a9b01754","artifact_type":"open_question","title":"Symptomatic agents","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-30221c46","artifact_type":"open_question","title":"Precision medicine","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-8ca17835","artifact_type":"open_question","title":"International CBD Genetics Consortium","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-18d8e4c7","artifact_type":"open_question","title":"Clinical trial networks","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-corticobasal-degeneration-1725489e","artifact_type":"open_question","title":"Patient registries","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-48725806","artifact_type":"open_question","title":"AAV vectors","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-8c474367","artifact_type":"open_question","title":"CRISPR-Cas13","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-146ee867","artifact_type":"open_question","title":"Prime editing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-e9186b02","artifact_type":"open_question","title":"Patient-derived iPSCs","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-e3ca0ff5","artifact_type":"open_question","title":"Cell replacement","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-d309095a","artifact_type":"open_question","title":"Gene correction","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-37b4771f","artifact_type":"open_question","title":"European Spinocerebellar Ataxia Registry (ESCAR)","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-fca6fda7","artifact_type":"open_question","title":"Clinical Research Consortium for SCA (CRC-SCA)","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-spinocerebellar-ataxia-type-2-54f605bf","artifact_type":"open_question","title":"International Ataxia Research Consortium (IARC)","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-als-ftd-spectrum-63690719","artifact_type":"open_question","title":"Biomarker development:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-als-ftd-spectrum-fe134960","artifact_type":"open_question","title":"Trial enrichment:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-als-ftd-spectrum-0b93dd7b","artifact_type":"open_question","title":"Combination therapies:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-als-ftd-spectrum-e5eafc0a","artifact_type":"open_question","title":"Personalized medicine:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-autonomic-dysfunction-in-corticobasal-syndrome-a3c2586e","artifact_type":"open_question","title":"Genetic subtyping","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-diseases-autonomic-dysfunction-in-corticobasal-syndrome-4fab9ce7","artifact_type":"open_question","title":"Biomarker stratification","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-e7960392-04d0-49e3-bb13-3dcf5c229f4c","artifact_type":"open_question","title":"Propagation mechanisms**: Can we determine the cell-to-cell transmission pathways for alpha-synuclein in MSA? Can we block them therapeutically?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:20.331452+00:00","updated_at":"2026-04-26T03:28:20.331452+00:00"}],"total":247,"limit":100,"offset":0,"returned":100,"sort":"importance_elo","field":"diseases"}